Hydrocortisone is not associated with a significant decrease in mortality from any cause 90 days after treatment in adults with septic shock, but still has other benefits, according to results published in NEJM Evidence today.

Literature review on out-of-pocket spending led by The George Institute for Global Health and NCD Alliance confirms devastating financial impact of NCDs on households in low- and middle-income countries alongside a crippling lack of data.